Evidence map›Paper›PMID 31686404›Full record

ArticleDrugs & aging2020

Correction to: Cost-Utility and Budget Impact Analysis for Stopping the Inappropriate Use of Proton Pump Inhibitors After Cessation of NSAID or Low‑Dose Acetylsalicylic Acid Treatment.

Sek Hung Chau, Reinier Luuk Sluiter, Jacqueline Geertruida Hugtenburg, Michel Wensing, Wietske Kievit, Martina Teichert

Abstract readPublished Erratum
In one paragraph

Article in Drugs & aging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Sek Hung ChauDepartment of Clinical Pharmacology and Pharmacy, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands. s.chau@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-0690-5009
Reinier Luuk SluiterDepartment for Health Evidence, Radboud University Medical Center, Geert Grooteplein 21, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0002-7422-968X
Jacqueline Geertruida HugtenburgDepartment of Clinical Pharmacology and Pharmacy, Amsterdam Public Health Research Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-6098-2438
Michel WensingRadboud University Medical Center, Scientific Institute for Quality of Healthcare (IQ Healthcare), Geert Grooteplein 21, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0001-6569-8137
Wietske KievitDepartment for Health Evidence, Radboud University Medical Center, Geert Grooteplein 21, Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0002-3984-1769
Martina TeichertDepartment of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, Leiden, The Netherlands.ORCID http://orcid.org/0000-0001-8411-3325

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Errors were subsequently identified in the article, and the following corrections should be noted.

Identifiers

PMID31686404
PMCPMC6965039

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.